The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Biodesix, Inc(NASDAQ:BDSX) 
Biodesix, Inc. operates a data-driven diagnostic solutions company in the United States. The company offers blood-based tests across the lung cancer continuum of care, such as Nodify XL2 and Nodify CDT tests to help physicians reclassify risk of malignancy in patients with suspicious lung nodules; a...
Website: http://www.biodesix.com
Founded: 2005
Full Time Employees: 186
CEO: Scott Hutton
Sector: Healthcare
Industry: Diagnostics & Research
Share this website to your friends
Biodesix Days Payable Outstanding ttm (DPO)
Biodesix Days Receivable Outstanding ttm (DSO)
Biodesix Days Inventory Outstanding ttm (DIO)
Biodesix Op Cashflow Per Share ttm
Biodesix Free Cashflow Per Share ttm
Biodesix Cash Per Share ttm
Biodesix P/S ratio ttm
Biodesix (GAAP) P/E ratio ttm
Biodesix P/B ratio ttm
No extra charts and metrics for this ticker.